IPAD-DB ID | C00849 |
Name | 3, 4, 5-Trihydroxycinnamic acid |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 9 H 8 O 5 |
Molecular Weight | 196.16g/mol |
IUPAC Name | (E)-3-(3, 4, 5-trihydroxyphenyl)prop-2-enoic acid |
InChI | InChI=1S/C9H8O5/c10-6-3-5(1-2-8(12)13)4-7(11)9(6)14/h1-4, 10-11, 14H, (H, 12, 13)/b2-1+ |
InChIKey | ACEAELOMUCBPJP-OWOJBTEDSA-N |
Canonical SMILES | C1=C(C=C(C(=C1O)O)O)C=CC(=O)O |
PubChem CID | 5382849 |
DrugBank Accession Number | - |
CAS Registry Number | 6093-59-0, 709007-50-1 |
Molecular Weight(Computed by SwissADME) | 196.16 |
Hac(Computed by SwissADME) | 14 |
Volume(Computed by ADMETlab 2.0) | 186.433 |
Density(Computed by ADMETlab 2.0) | 1.052 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 0.25 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -0.829 |
LogD(Computed by ADMETlab 2.0) | 0.36 |
logP(Computed by ADMETlab 2.0) | 0.9 |
TPSA(Computed by SwissADME) | 97.99 Ų |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.66 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | No, 1 violation: MW<200 |
Bioavailability Score(Computed by SwissADME) | 0.56 |